Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
New BHF Chief Technology Officer Appointed
British Heart Foundation are delighted to have appointed Alex Duncan as their new Chief Technology Officer (CTO). Alex, who is […]
New Clot Busting Drug Could Improve Stroke Treatment
A new clot busting drug developed by scientists at the University of Manchester is able […]
NHS Offers Home Blood Pressure Checks to Save Thousands of Lives
Hundreds of thousands of people will be able to test their blood pressure at home, […]
BHF Teams Up With The Francis Crick Institute to Bolster Cardiovascular Research
BHF have teamed up with the Francis Crick Institute to improve understanding of cardiovascular health […]
New Technique Makes Heart Transplant Possible for More Children in Need
A new technique developed by researchers BHF funded at Great Ormond Street Hospital for Children […]
BHF Research Could Help Detect Early Signs of Heart Failure in Diabetic Patients
New research that BHF have funded in Leicester could help understand how heart failure can […]
AI Breakthrough for Faster, Cheaper and Injection-free Heart Scans
New artificial intelligence (AI) technology could lead to the next generation of heart MRI scans […]
New Research to Study Benefits of Personalised Pacemaker Programming
Researchers BHF have funded at the University of Leeds will investigate how people living with […]
Genes Responsible for High Blood Pressure Discovered in the Human Kidney
Research that the British Heart Foundation part-funded has led to the discovery of 179 kidney […]
Glowing Probe Could Diagnose Cardiovascular Disease Earlier
Researchers have created a probe that glows when it detects an enzyme associated with issues […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more